Fig. 2From: Inhibition of CPT1a as a prognostic marker can synergistically enhance the antileukemic activity of ABT199a Global metabolomics profile between high and low expression of CPT1a of 12 patients. b Volcano plot of differential gene profiles between high and low expression of CPT1a of 22 patientsBack to article page